Buy Vivimed Labs above Rs 260: Shardul Kulkarni

Buy Vivimed Labs above Rs 260, says Shardul Kulkarni of Angel Broking.

Kulkarni told CNBC-Awaaz, "Vivimed Labs is trading with low volume. The stock is looking weak below Rs 260. One can buy the stock above Rs 260."
The company's trailing 12-month (TTM) EPS was at Rs 31.74 per share. (Jun 2011). The stock's price-to-earnings (P/E) ratio was 7.65. The latest book value of the company is Rs 143.09 per share. At current value, the price-to-book value of the company was 1.7. The dividend yield of the company was 0.62%.